Quest Diagnostics, Inc. (DGX)
242.77
-1.84
(-0.75%)
USD |
NYSE |
Aug 28, 16:00
242.77
0.00 (0.00%)
After-Hours: 16:41
Quest Diagnostics Cash from Operations (Quarterly) : 597.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 597.00M |
| March 31, 2026 | 278.00M |
| December 31, 2025 | 465.00M |
| September 30, 2025 | 563.00M |
| June 30, 2025 | 544.00M |
| March 31, 2025 | 314.00M |
| December 31, 2024 | 464.00M |
| September 30, 2024 | 356.00M |
| June 30, 2024 | 360.00M |
| March 31, 2024 | 154.00M |
| December 31, 2023 | 527.00M |
| September 30, 2023 | 207.00M |
| June 30, 2023 | 444.00M |
| March 31, 2023 | 94.00M |
| December 31, 2022 | 334.00M |
| September 30, 2022 | 502.00M |
| June 30, 2022 | 402.00M |
| March 31, 2022 | 480.00M |
| December 31, 2021 | 481.00M |
| September 30, 2021 | 561.00M |
| June 30, 2021 | 460.00M |
| March 31, 2021 | 731.00M |
| December 31, 2020 | 541.00M |
| September 30, 2020 | 862.00M |
| June 30, 2020 | 355.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 247.00M |
| December 31, 2019 | 348.00M |
| September 30, 2019 | 299.00M |
| June 30, 2019 | 321.00M |
| March 31, 2019 | 275.00M |
| December 31, 2018 | 295.00M |
| September 30, 2018 | 402.00M |
| June 30, 2018 | 323.00M |
| March 31, 2018 | 180.00M |
| December 31, 2017 | 323.00M |
| September 30, 2017 | 362.00M |
| June 30, 2017 | 294.00M |
| March 31, 2017 | 196.00M |
| December 31, 2016 | 304.00M |
| September 30, 2016 | 301.00M |
| June 30, 2016 | 311.00M |
| March 31, 2016 | 153.00M |
| December 31, 2015 | 271.00M |
| September 30, 2015 | 212.00M |
| June 30, 2015 | 275.00M |
| March 31, 2015 | 52.00M |
| December 31, 2014 | 303.00M |
| September 30, 2014 | 271.00M |
| June 30, 2014 | 280.00M |
| March 31, 2014 | 84.00M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 445.50M |
| DaVita, Inc. | 490.07M |
| OPKO Health, Inc. | -43.50M |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | 19.96M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -134.00M |
| Cash from Financing (Quarterly) | -229.00M |
| Free Cash Flow | 1.349B |
| Free Cash Flow Per Share (Quarterly) | 4.098 |
| Free Cash Flow to Equity (Quarterly) | 482.00M |
| Free Cash Flow to Firm (Quarterly) | 495.17M |
| Free Cash Flow Yield | 4.95% |